Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape

Chen, Zhoumiao; Chen, Zhao; Xu, Shaohua; Zhang, Qiang

doi:10.3389/fgene.2022.857986

CORRECTION article

Front. Genet. , 03 March 2022

Sec. Epigenomics and Epigenetics

Volume 13 - 2022 | https://doi.org/10.3389/fgene.2022.857986

This article is part of the Research Topic Finding New Epigenomics and Epigenetics Biomarkers for Complex Diseases and Significant Developmental Events with Machine Learning Methods View all 36 articles

Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape

This article is a correction to:

LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-small Cell Lung Cancer Progression and Immune Escape
1. Read original article

Zhoumiao Chen*

Zhao Chen

Shaohua Xu

Qiang Zhang

Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China

A corrigendum on
LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-small Cell Lung Cancer Progression and Immune Escape

by Chen, Z., Chen, Z., Xu, S., and Zhang, Q. (2021). Front. Genet. 12:674856. doi: 10.3389/fgene.2021.674856

There is an error in the Funding statement. The correct number for Zhejiang Provincial Natural

Science Foundation of China “No. Q19H280028” is “No. LQ19H280007.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: non-small cell lung cancer, competing endogenous RNA, SOX2-OT, mTOR, PD-L1

Citation: Chen Z, Chen Z, Xu S and Zhang Q (2022) Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape. Front. Genet. 13:857986. doi: 10.3389/fgene.2022.857986

Received: 21 January 2022; Accepted: 25 January 2022;
Published: 03 March 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Chen, Chen, Xu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhoumiao Chen, MzE5MzA4NEB6anUuZWR1LmNu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Corrigendum: LncRNA SOX2-OT/miR-30d-5p/PDK1 Regulates PD-L1 Checkpoint Through the mTOR Signaling Pathway to Promote Non-Small Cell Lung Cancer Progression and Immune Escape

Publisher’s Note

95% of researchers rate our articles as excellent or good

95% of researchers rate our articles as excellent or good